Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Havenith

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solutionLiesbeth H P Hekking, Mohammad Zareie, Bas A J Driesprong, et al.
Blood|January 5, 2018
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignanciesFrancesca Zammarchi, Simon Corbett, Lauren Adams, et al.
Scientific Reports|July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirineJohn A Hartley, Michael J Flynn, John P Bingham, et al.
Molecular Cancer Therapeutics|August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological MalignanciesMichael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
Annals of Surgical Oncology|August 27, 2014
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.
Molecular Cancer Therapeutics|August 2, 2018
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate CancerSong Cho, Francesca Zammarchi, David G Williams, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Better preservation of peritoneal morphologic features and defense in rats after long-term exposure to a bicarbonate/lactate-buffered solutionLiesbeth H P Hekking, Mohammad Zareie, Bas A J Driesprong, et al.
Blood|January 5, 2018
ADCT-402, a PBD dimer-containing antibody drug conjugate targeting CD19-expressing malignanciesFrancesca Zammarchi, Simon Corbett, Lauren Adams, et al.
Scientific Reports|July 12, 2018
Pre-clinical pharmacology and mechanism of action of SG3199, the pyrrolobenzodiazepine (PBD) dimer warhead component of antibody-drug conjugate (ADC) payload tesirineJohn A Hartley, Michael J Flynn, John P Bingham, et al.
Molecular Cancer Therapeutics|August 19, 2016
ADCT-301, a Pyrrolobenzodiazepine (PBD) Dimer-Containing Antibody-Drug Conjugate (ADC) Targeting CD25-Expressing Hematological MalignanciesMichael J Flynn, Francesca Zammarchi, Peter C Tyrer, et al.
Annals of Surgical Oncology|August 27, 2014
Consequence of restaging after neoadjuvant treatment for locally advanced rectal cancerC Bisschop, J J J Tjalma, G A P Hospers, et al.
Molecular Cancer Therapeutics|August 2, 2018
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate CancerSong Cho, Francesca Zammarchi, David G Williams, et al.
Pageof 9